Our Areas of Focus

With patients at the core of everything we do, we are continuously seeking ways to improve the treatment paradigm for patients with rare genetic epilepsies and seizure disorders.

Icon Status Epilepticus

Status Epilepticus (SE)

Status epilepticus is the occurrence of an epileptic seizure of a prolonged duration of more than five minutes or several seizures within a five-minute period where the individual does not recover between seizures.

Icon Cdlk5

CDKL5 Deficiency Disorder (CDD)

CDKL5 deficiency disorder (CDD) is a serious and rare genetic disorder that is caused by a mutation of the cyclin-dependent kinase-like 5 (CDKL5) gene, located on the X chromosome.

Icon Tuberous Sclerosis

Tuberous Sclerosis Complex (TSC)

Tuberous sclerosis complex (TSC) is a rare genetic disorder that affects many organs and causes non-malignant tumors in the brain, skin, kidney, heart, eyes, and lungs.

Information about Marinus’ clinical trials can be found on ClinicalTrials.gov.